Celgene Corp (CELG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CELG | AZN | AMGN | GILD | VRTX |
| Company | Celgene Corp | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 108.01 | 89.40 | 317.30 | 122.86 | 444.81 |
| High | 108.59 | 89.89 | 319.46 | 123.63 | 456.00 |
| Low | 107.27 | 89.28 | 315.19 | 120.24 | 444.81 |
| Latest | 108.24 | 89.69 | 316.52 | 120.48 | 451.98 |
| Change | +0.11 | -0.60 | -0.86 | -2.73 | +6.05 |
| % Change | +0.10% | -0.66% | -0.27% | -2.22% | +1.36% |
| Volume | 191,230,496 | 3,170,970 | 1,006,676 | 2,842,757 | 890,459 |
| 20-Day Average Volume | 16,188,930 | 5,575,448 | 2,796,222 | 6,848,437 | 1,351,601 |
| Previous Close | 108.13 | 90.29 | 317.38 | 123.21 | 445.93 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 108.17 | 90.59 | 333.99 | 124.26 | 437.61 |
| 20-Day Raw Stochastic | 63.25% | 24.93% | 12.75% | 25.04% | 72.55% |
| 20-Day Relative Strength | 64.69 | 55.02 | 47.17 | 48.62 | 59.10 |
| Weighted Alpha | +46.30 | +37.57 | +17.02 | +29.02 | +1.46 |
| Today's Opinion | 100% Buy | 88% Buy | 72% Buy | 56% Buy | 40% Buy |
| Previous Opinion | 100% Buy | 88% Buy | 72% Buy | 72% Buy | 40% Buy |
| Last Month's Opinion | 100% Buy | 100% Buy | 56% Buy | 100% Buy | 8% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.97% since 11/13/19 | -0.52% since 12/05/25 | -3.99% since 12/05/25 | +0.03% since 12/05/25 | -0.89% since 12/05/25 |
| Low | 107.27 on 11/20/19 | 89.29 on 12/12/25 | 312.39 on 12/11/25 | 118.78 on 12/10/25 | 433.81 on 12/10/25 |
| High | 110.53 on 11/14/19 | 91.66 on 12/10/25 | 329.67 on 12/08/25 | 123.74 on 12/11/25 | 457.17 on 12/08/25 |
| 1-Month | |||||
| %Chg | +5.14% since 10/18/19 | +2.32% since 11/12/25 | -5.82% since 11/12/25 | -1.73% since 11/12/25 | +3.97% since 11/12/25 |
| Low | 102.40 on 10/21/19 | 87.62 on 11/13/25 | 312.39 on 12/11/25 | 118.78 on 12/10/25 | 418.53 on 11/19/25 |
| High | 110.70 on 11/13/19 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 3-Month | |||||
| %Chg | +13.63% since 08/20/19 | +12.76% since 09/12/25 | +14.59% since 09/12/25 | +5.86% since 09/12/25 | +14.42% since 09/12/25 |
| Low | 93.41 on 08/23/19 | 72.89 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 374.17 on 09/24/25 |
| High | 110.70 on 11/13/19 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 6-Month | |||||
| %Chg | +14.14% since 05/20/19 | +19.61% since 06/12/25 | +6.54% since 06/12/25 | +8.22% since 06/12/25 | -1.88% since 06/12/25 |
| Low | 89.08 on 07/23/19 | 68.61 on 07/21/25 | 267.83 on 06/23/25 | 104.46 on 06/25/25 | 362.50 on 08/11/25 |
| High | 110.70 on 11/13/19 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 484.56 on 07/10/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 77,035,920 | 280,027,776 | 170,903,104 | 152,864,192 | 113,140,912 |
| Shares Outstanding, K | 711,714 | 3,101,426 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 15,281,000,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | 4,046,000,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 4,520,000,000 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | 1,691,000,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | 1.41 | 0.32 | 0.45 | 0.32 | 0.32 |
| Per-Share Information | |||||
| Most Recent Earnings | 2.99 on 10/31/19 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 01/30/20 | 02/05/26 | 02/03/26 | 02/10/26 | 02/09/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 10.99 | 20.02 | 14.42 | 14.82 | 29.04 |